283 related articles for article (PubMed ID: 29664124)
21. [S2k guidelines of the German Society of Urology. Management and implementation of intermittent catheterization in neurogenic bladder dysfunction].
Kurze I; Geng V; Böthig R
Urologe A; 2015 Mar; 54(3):385-93. PubMed ID: 25784447
[TBL] [Abstract][Full Text] [Related]
22. Intradetrusor onabotulinumtoxinA injections for refractory neurogenic detrusor overactivity incontinence: do we need urodynamic investigation for outcome assessment?
Koschorke M; Leitner L; Sadri H; Knüpfer SC; Mehnert U; Kessler TM
BJU Int; 2017 Dec; 120(6):848-854. PubMed ID: 28771936
[TBL] [Abstract][Full Text] [Related]
23. Comparison of neurogenic lower urinary tract dysfunctions in open versus closed spinal dysraphism: A prospective cross-sectional study of 318 patients.
Peyronnet B; Brochard C; Jezequel M; Hascoet J; Alimi Q; Senal N; Carsin-Nicole B; Riffaud L; Le Reste PJ; Bonan I; Olivari-Philiponnet C; Siproudhis L; Kerdraon J; Game X; Manunta A
Neurourol Urodyn; 2018 Nov; 37(8):2818-2826. PubMed ID: 30070396
[TBL] [Abstract][Full Text] [Related]
24. European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence.
Nambiar AK; Arlandis S; Bø K; Cobussen-Boekhorst H; Costantini E; de Heide M; Farag F; Groen J; Karavitakis M; Lapitan MC; Manso M; Arteaga SM; Riogh ANA; O'Connor E; Omar MI; Peyronnet B; Phé V; Sakalis VI; Sihra N; Tzelves L; van Poelgeest-Pomfret ML; van den Bos TWL; van der Vaart H; Harding CK
Eur Urol; 2022 Jul; 82(1):49-59. PubMed ID: 35216856
[TBL] [Abstract][Full Text] [Related]
25. Variation in Provider Practice Patterns and the Perceived Need for a Shared Decision-making Tool for Neurogenic Lower Urinary Tract Dysfunction.
Fendereski K; Hebert KJ; Matta R; Myers JB
Urology; 2023 Apr; 174():185-190. PubMed ID: 36709856
[TBL] [Abstract][Full Text] [Related]
26. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology.
Groen J; Pannek J; Castro Diaz D; Del Popolo G; Gross T; Hamid R; Karsenty G; Kessler TM; Schneider M; 't Hoen L; Blok B
Eur Urol; 2016 Feb; 69(2):324-33. PubMed ID: 26304502
[TBL] [Abstract][Full Text] [Related]
27. [EAU Guidelines on Urinary Incontinence].
Thüroff JW; Abrams P; Andersson KE; Artibani W; Chapple CR; Drake MJ; Hampel C; Neisius A; Schröder A; Tubaro A;
Actas Urol Esp; 2011; 35(7):373-88. PubMed ID: 21600674
[TBL] [Abstract][Full Text] [Related]
28. Are EAU/ESPU pediatric urology guideline recommendations on neurogenic bladder well received by the patients? Results of a survey on awareness in spina bifida patients and caregivers.
Dogan HS; Stein R; 't Hoen LA; Bogaert G; Nijman RJM; Tekgul S; Quaedackers J; Silay MS; Radmayr C
Neurourol Urodyn; 2019 Aug; 38(6):1625-1631. PubMed ID: 31102557
[TBL] [Abstract][Full Text] [Related]
29. Systematic review of guidelines for urinary incontinence in women.
Favre-Inhofer A; Dewaele P; Millet P; Deffieux X
J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101842. PubMed ID: 32592767
[TBL] [Abstract][Full Text] [Related]
30. Review of the current management of lower urinary tract injuries by the EAU Trauma Guidelines Panel.
Lumen N; Kuehhas FE; Djakovic N; Kitrey ND; Serafetinidis E; Sharma DM; Summerton DJ
Eur Urol; 2015 May; 67(5):925-9. PubMed ID: 25576009
[TBL] [Abstract][Full Text] [Related]
31. [European Association of Urology guidelines on assessment and nonsurgical management of urinary incontinence].
Lucas MG; Bosch RJ; Burkhard FC; Cruz F; Madden TB; Nambiar AK; Neisius A; de Ridder DJ; Tubaro A; Turner WH; Pickard RS;
Actas Urol Esp; 2013 Apr; 37(4):199-213. PubMed ID: 23452548
[TBL] [Abstract][Full Text] [Related]
32. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation.
Ginsberg DA; Boone TB; Cameron AP; Gousse A; Kaufman MR; Keays E; Kennelly MJ; Lemack GE; Rovner ES; Souter LH; Yang CC; Kraus SR
J Urol; 2021 Nov; 206(5):1097-1105. PubMed ID: 34495687
[TBL] [Abstract][Full Text] [Related]
33. EAU guidelines on robotic and single-site surgery in urology.
Merseburger AS; Herrmann TR; Shariat SF; Kyriazis I; Nagele U; Traxer O; Liatsikos EN;
Eur Urol; 2013 Aug; 64(2):277-91. PubMed ID: 23764016
[TBL] [Abstract][Full Text] [Related]
34. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
[TBL] [Abstract][Full Text] [Related]
35. Use of botulinum toxin for genitourinary conditions: What is the evidence?
da Silva CM; Chancellor MB; Smith CP; Cruz F
Toxicon; 2015 Dec; 107(Pt A):141-7. PubMed ID: 26235907
[TBL] [Abstract][Full Text] [Related]
36. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
[TBL] [Abstract][Full Text] [Related]
37. Catheterization for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Tornic J; Sartori AM; Gajewski JB; Cox A; Schneider MP; Youssef NA; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
Neurourol Urodyn; 2018 Nov; 37(8):2315-2322. PubMed ID: 29917273
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
[TBL] [Abstract][Full Text] [Related]
39. [The role of the urologist in the treatment of obstructions of the lower urinary tract in children with neurogenic bladder].
Cukier J; Beurton D
J Urol Nephrol (Paris); 1972 Mar; 78(3):207-14. PubMed ID: 4646914
[No Abstract] [Full Text] [Related]
40. [Botulinum toxin for the treatment of neurogenic detrusor hyperactivity. Consensus paper on use for neurogenic bladder dysfunction].
Sievert KD; Bremer J; Burgdörfer H; Domurath B; Hampel C; Kutzenberger J; Seif C; Stöhrer M; Wefer B; Pannek J
Urologe A; 2007 Mar; 46(3):293-6. PubMed ID: 17295036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
